Nanopath Secures $10M to Develop POC Diagnostics for Women’s Health
[ad_1] Nanopath, a molecular diagnostics company enabling high-quality molecular testing in minutes, has closedย $10 millionย in Series A funding that will support development and commercialization of the companyโs biosensing platform that […]
Nanopath Secures $10M to Develop POC Diagnostics for Women’s Health Read More ยป






















